tiprankstipranks
Bluebird Bio completes commercial cell collection for LYFGENIA
PremiumThe FlyBluebird Bio completes commercial cell collection for LYFGENIA
22d ago
Bluebird Bio Faces Nasdaq Compliance Challenge and Delays
PremiumCompany Announcements
Bluebird Bio Faces Nasdaq Compliance Challenge and Delays
1M ago
Bluebird Bio receives expected notice from Nasdaq
PremiumThe Fly
Bluebird Bio receives expected notice from Nasdaq
1M ago
Bluebird Bio price target lowered to $3 from $4 at Wells Fargo
PremiumThe FlyBluebird Bio price target lowered to $3 from $4 at Wells Fargo
2M ago
Options Volatility and Implied Earnings Moves Today, March 26, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 26, 2024
2M ago
Bluebird Bio reports Q4 revenue $7.8M, consensus $16.68M	.
PremiumThe Fly
Bluebird Bio reports Q4 revenue $7.8M, consensus $16.68M .
2M ago
Bluebird Bio provides update on commercial launch, announces factoring deal
PremiumThe FlyBluebird Bio provides update on commercial launch, announces factoring deal
5M ago
Short Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt
PremiumThe Fly
Short Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt
5M ago
Bluebird Bio price target lowered to $5 from $12 at BofA
PremiumThe Fly
Bluebird Bio price target lowered to $5 from $12 at BofA
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100